Edwards Lifesciences Corp (EW)
$85.78
$2.58
(3.10%)
As on 22-May-2026 19:00EDT
Market cap
$49,392 Mln
Revenue (TTM)
$6,304 Mln
P/E Ratio
46.4
P/B Ratio
4.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$716 Mln
-
ROE
0.1 %
-
ROCE
9.9 %
-
Industry P/E
45.4
-
EV/EBITDA
28.8
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$1.9
-
Face value
--
-
Shares outstanding
575,800,000
10 Years Aggregate
CFO
$10,283.70 Mln
EBITDA
$11,661.20 Mln
Net Profit
$9,517.50 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
| 0.6 | 7.6 | 7.5 | 12.7 | -0.8 | -1.9 | 10.0 |
|
BSE Sensex*
| -9.7 | -0.2 | -7.0 | -6.4 | 7.4 | 8.6 | 11.7 |
|
S&P 100
| 7.4 | 6.7 | 10.0 | 30.6 | 24.2 | 14.5 | 15.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
| 15.2 | -2.9 | 2.2 | -42.4 | 42.0 | 17.3 | 52.3 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
85.8 | 49,392.1 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46.4 | 4.6 |
| 87.4 | 152,878.9 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.6 | 2.9 | |
| 147.6 | 40,490.7 | 21,365.0 | 1,138.0 | 9.9 | 4.6 | 25.6 | 1.7 | |
| 57.8 | 84,945.2 | 20,615.0 | 3,553.0 | 10.0 | 14.5 | 23.9 | 3.3 | |
| 172.0 | 121,113.7 | 24,778.0 | 3,689.0 | 18.7 | 7.1 | 33.1 | 2.3 | |
| 559.4 | 44,124.8 | 4,446.1 | 1,095.2 | 23.5 | 70.3 | 41.2 | 28.4 | |
| 438.1 | 155,158.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 53.2 | 8.9 | |
| 316.5 | 120,183.6 | 25,270.0 | 3,337.0 | 18.5 | 15.1 | 36.2 | 5.2 | |
| 448.3 | 166,995.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.7 | 3.2 | |
| 342.4 | 33,615.9 | 3,770.6 | 449.3 | 16.3 | 5.1 | 43.4 | 2.2 |
Shareholding Pattern
View DetailsAbout Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive... replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Read more
-
CEO & Director
Mr. Bernard J. Zovighian
-
CEO & Director
Mr. Bernard J. Zovighian
-
Headquarters
Irvine, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Edwards Lifesciences Corp (EW)
What is the current share price of Edwards Lifesciences Corp (EW) Today?
The share price of Edwards Lifesciences Corp (EW) is $85.78 (NYSE) as of 22-May-2026 19:00 EDT. Edwards Lifesciences Corp (EW) has given a return of -0.82% in the last 3 years.
What is the current PB & PE ratio of Edwards Lifesciences Corp (EW)?
The P/E ratio of Edwards Lifesciences Corp (EW) is 46.37 times as on 22-May-2026, a 2 premium to its peers’ median range of 45.40 times.
The P/B ratio of Edwards Lifesciences Corp (EW) is 4.64 times as on 22-May-2026, a 49 premium to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
46.20
|
4.80
|
|
2024
|
10.47
|
4.37
|
|
2023
|
33.00
|
6.96
|
|
2022
|
30.21
|
7.92
|
|
2021
|
54.47
|
14.03
|
What is the 52 Week High and Low of Edwards Lifesciences Corp (EW)?
The 52-week high and low of Edwards Lifesciences Corp (EW) are Rs 87.89 and Rs 72.30 as of 25-May-2026.
What is the market cap of Edwards Lifesciences Corp (EW)?
Edwards Lifesciences Corp (EW) has a market capitalisation of $ 49,392 Mln as on 22-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Edwards Lifesciences Corp (EW)?
Before investing in Edwards Lifesciences Corp (EW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.